CMED: The ‘Curupira’ of Brazil’s Pharma Market
Published: | Updated:
Outlining one country’s unique price-setting model for novel drugs-and the resulting pre-launch strategies for manufacturers.
Catarina Costa Pinheiro
Advertisement
Articles by Catarina Costa Pinheiro
Advertisement
Latest Updated Articles
CMED: The ‘Curupira’ of Brazil’s Pharma MarketPublished: February 21st 2017 | Updated: November 15th 2020
Advertisement
Advertisement
Trending on PharmExec
1
The Influence of Trump Rx in Pharmacy Benefit Managers, Retail Pharmacies, and Digital Health Platforms
2
Bringing HIV Prevention DTC: Q&A with Ashley Gildea
3
Leading in the Psychedelic Space: Q&A with Tarek Rabah
4
FDA Approves Hernexeos Under National Priority Voucher Program
5